Trial · NCT04431791
Real World Study of Regorafenib Versus Fruquintinib in Colorectal Cancer
NCT04431791, Unknown, Peking University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Real World Study of Regorafenib Versus Fruquintinib in Colorectal Cancer. Trials, record NCT04431791. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04431791
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Real World Study of Regorafenib Versus Fruquintinib in Colorectal Cancer
- NCT number
- NCT04431791
- Status
- Unknown
- Enrollment
- 268 participants, estimated
- Lead sponsor
- Peking University
- Conditions
- Colorectal Cancer
- Interventions
- Regorafenib, Fruquintinib
- First posted
- 2020-06-16
- Last updated
- 2020-06-16
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time To Treatment Failure | every month, up to discontinuation of treatment for any reason. | the time from first dose to discontinuation of treatment for any reason, including disease progression, treatment toxicity, and death. |
| Secondary | Overall survival | from enrollment of the first subject until the database cut-off approximately 6 months later. | the time from first dose to the death for any cause. |
| Secondary | Progression-free survival | from enrollment of the first subject until the database cut-off approximately 6 months later. | the time from first dose to disease progression. |
| Secondary | Incidence of adverse events（AEs） | from the first dose to discontinuation of treatment for any reason, including disease progression, treatment toxicity, and death. | percentage of patients with AEs according to CTCAE 4.03 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04431791
GET https://conductscience.org/api/trials/v1/NCT04431791/registered